These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6137389

  • 1. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T, Ohnishi A, Sasaki T, Kushida K, Horai Y, Chiba K, Suganuma T.
    Eur J Clin Pharmacol; 1983; 25(1):95-101. PubMed ID: 6137389
    [Abstract] [Full Text] [Related]

  • 2. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
    Morita S, Iinuma M, Kido M, Sakuragi S, Kohri H, Nishino H.
    Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of carteolol in relation to renal function.
    Hasenfuss G, Schäfer-Korting M, Knauf H, Mutschler E, Just H.
    Eur J Clin Pharmacol; 1985; 29(4):461-5. PubMed ID: 4092726
    [Abstract] [Full Text] [Related]

  • 4. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J, Smith RP, Ferguson RA.
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic studies in patients with nadolol: oral and intravenous administration.
    Dreyfuss J, Brannick LJ, Vukovich RA, Shaw JM, Willard DA.
    J Clin Pharmacol; 1977; 17(5-6):300-7. PubMed ID: 16040
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of betaxolol in middle aged patients.
    Bianchetti G, Thiercelin JF, Thenot JP.
    Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of pamatolol, a cardioselective beta adrenoreceptor blocker.
    Carruthers SG, Pentikainen P, Hosler JP, Azarnoff DL.
    Clin Pharmacol Ther; 1979 Dec; 26(6):682-5. PubMed ID: 40725
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of a single intravenous and oral dose of pafenolol--a beta 1-adrenoceptor antagonist with atypical absorption and disposition properties--in man.
    Regårdh CG, Lundborg P, Gabrielsson M, Heggelund A, Kylberg-Hanssen K.
    Pharm Res; 1990 Dec; 7(12):1222-7. PubMed ID: 1982773
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G, Blatrix C, Gomeni R, Kilborn JR, Larribaud J, Lücker PW, Thebault JJ, Trocherie S, Morselli PL.
    Arzneimittelforschung; 1980 Dec; 30(11):1912-6. PubMed ID: 6109538
    [Abstract] [Full Text] [Related]

  • 13. [Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic blocking agent. (6) Pharmacokinetics of carteolol in the rat, dog, rabbit and man].
    Morita S, Irie Y, Sakuragi S, Kori H.
    Nihon Yakurigaku Zasshi; 1977 Mar; 73(2):229-35. PubMed ID: 328355
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Animal experimental studies on the pharmacokinetics of carteolol].
    Lang W.
    Arzneimittelforschung; 1983 Mar; 33(2a):286-9. PubMed ID: 6682319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man.
    Houin G, Barre J, Jeanniot JP, Ledudal P, Cautreels W, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Mar; 4(3):175-83. PubMed ID: 6149195
    [Abstract] [Full Text] [Related]

  • 18. Butofilolol pharmacokinetics in chronic renal insufficiency.
    Jeanniot JP, Houin G, Ledudal P, Cautreels W, Giudicelli CP, Tillement JP.
    Int J Clin Pharmacol Res; 1984 Mar; 4(3):165-73. PubMed ID: 6149194
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interactions of carteolol and other beta-adrenoceptor blocking agents with serotonin receptor subtypes.
    Nishio H, Nagakura Y, Segawa T.
    Arch Int Pharmacodyn Ther; 1989 Mar; 302():96-106. PubMed ID: 2576893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.